A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine

Overview of attention for article published in BMC Cancer, December 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

blogs: 1 blog

twitter: 6 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 63 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 8 X posts from 6 X users, with an upper bound of 3,603 followers.

RT @WUTHlibrary: CCC publication: A Systematic Review of Lenvatinib and Sorafenib for Treating Progressive, Locally Advanced or Metastatic,…

20 Jan 2020

Reply Repost Favourite

CCC publication: A Systematic Review of Lenvatinib and Sorafenib for Treating Progressive, Locally Advanced or Metastatic, Differentiated Thyroid Cancer After Treatment With Radioactive Iodine https://t.co/CPPjeaINzp @CCC_Staff #openaccess #healthresearch

20 Jan 2020

Reply Repost Favourite

RT @LivUniLRiG: This research from the @LivUniLRiG team has now also been published as a #HTA monograph @NIHRresearch "Lenvatinib and sor…

14 Jan 2020

Reply Repost Favourite

This research from the @LivUniLRiG team has now also been published as a #HTA monograph @NIHRresearch "Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation" https://t.co/EVWMXPth

14 Jan 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.